<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20356" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Dentatorubral Pallidoluysian Atrophy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rocha Cabrero</surname>
            <given-names>Franklyn</given-names>
          </name>
          <aff>University of Miami/Jackson Memorial Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>De Jesus</surname>
            <given-names>Orlando</given-names>
          </name>
          <aff>University of Puerto Rico, Medical Sciences Campus, Neurosurgery Section</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Franklyn Rocha Cabrero declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Orlando De Jesus declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>23</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20356.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Dentatorubral-pallidoluysian atrophy (DRPLA) is a progressive, autosomal dominant disorder with symptoms and severity that vary with the age of onset. Identifying cardinal features of adult and juvenile DRPLA can guide a neurologist towards diagnosis and supportive treatment of symptoms. Given the autosomal dominant inheritance, genetic counseling is important given the level of functional impairment caused by this disorder. This activity will highlight the importance of the interprofessional team in the evaluation and management of DRPLA, including post-diagnosis counseling and symptomatic management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of dentatorubral-pallidoluysian atrophy.</p></list-item><list-item><p>Describe the history and physical findings in patients with dentatorubral-pallidoluysian atrophy.</p></list-item><list-item><p>Review the management options available for dentatorubral-pallidoluysian atrophy.</p></list-item><list-item><p>Summarize the role of the interprofessional team in managing patients suffering from DRPLA.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20356&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20356">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-20356.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Dentatorubral-pallidoluysian atrophy (DRPLA) is a progressive autosomal dominant disorder characterized by myoclonic epilepsy, ataxia, choreoathetosis/dystonia, cognitive impairment/dementia, and psychiatric disturbances.<xref ref-type="bibr" rid="article-20356.r1">[1]</xref><xref ref-type="bibr" rid="article-20356.r2">[2]</xref><xref ref-type="bibr" rid="article-20356.r3">[3]</xref><xref ref-type="bibr" rid="article-20356.r4">[4]</xref><xref ref-type="bibr" rid="article-20356.r5">[5]</xref><xref ref-type="bibr" rid="article-20356.r4">[4]</xref><xref ref-type="bibr" rid="article-20356.r3">[3]</xref><xref ref-type="bibr" rid="article-20356.r1">[1]</xref> Rarely, corneal endothelial degeneration, head tremor, or optic atrophy&#x000a0;may be present.<xref ref-type="bibr" rid="article-20356.r6">[6]</xref><xref ref-type="bibr" rid="article-20356.r7">[7]</xref><xref ref-type="bibr" rid="article-20356.r8">[8]</xref><xref ref-type="bibr" rid="article-20356.r7">[7]</xref><xref ref-type="bibr" rid="article-20356.r6">[6]</xref>&#x000a0;The presentation varies with the age of onset. The disorder was first described in 1946,&#x000a0;and the name was given in1958.<xref ref-type="bibr" rid="article-20356.r9">[9]</xref><xref ref-type="bibr" rid="article-20356.r10">[10]</xref><xref ref-type="bibr" rid="article-20356.r9">[9]</xref></p>
      </sec>
      <sec id="article-20356.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Dentatorubral-pallidoluysian atrophy is a cytosine, adenine, and guanine (CAG) trinucleotide repeat expansion in the atrophin-1 (ATN1) gene, in exon 5.<xref ref-type="bibr" rid="article-20356.r3">[3]</xref><xref ref-type="bibr" rid="article-20356.r11">[11]</xref>&#x000a0;This gene on chromosome 12p13.31, encodes a transcriptional co-repressor expressed in the central nervous system (CNS) and other organs in the body.<xref ref-type="bibr" rid="article-20356.r12">[12]</xref>&#x000a0;Normal CAG repeats range between 6-35. Pathogenic&#x000a0;CAG repeat length can range from 48 to 93, with higher repeat length correlated with worse disease severity, in most cases.<xref ref-type="bibr" rid="article-20356.r13">[13]</xref><xref ref-type="bibr" rid="article-20356.r14">[14]</xref></p>
        <p>Some exceptions are&#x000a0;reported in rare cases of asymptomatic patients with high CAG repeats. Complete penetrance of the condition is more than 48 tandem copies, which have a typical clinical presentation. Incomplete penetrance phenotypes are&#x000a0;found in patients with alleles of 35&#x000a0;to 47 repeat length, associated with a milder clinical phenotype.&#x000a0;Japanese patients have a higher number of baseline CAG repeats, 20&#x000a0;to 35, compared to people of European&#x000a0;descent.<xref ref-type="bibr" rid="article-20356.r15">[15]</xref><xref ref-type="bibr" rid="article-20356.r16">[16]</xref>&#x000a0;The clinical-genetic phenomenology of non-Asian DRPLA is similar to the Asian DRPLA.<xref ref-type="bibr" rid="article-20356.r17">[17]</xref></p>
      </sec>
      <sec id="article-20356.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Dentatorubral-pallidoluysian atrophy has a median age of onset of&#x000a0;31 years of age. It mainly affects&#x000a0;Asian populations, in particular, the Japanese population. The&#x000a0;incidence&#x000a0;is approximately 2&#x000a0;to 7 per million people in the Japanese population.<xref ref-type="bibr" rid="article-20356.r12">[12]</xref><xref ref-type="bibr" rid="article-20356.r18">[18]</xref>&#x000a0;The prevalence of DRPLA in Japanese people has been estimated to be 0.2 to 0.4 per 100,000.<xref ref-type="bibr" rid="article-20356.r19">[19]</xref>&#x000a0;Although DRPLA was initially recognized in Asian populations, wider genetic testing has increased diagnosis in other ethnic groups/families.<xref ref-type="bibr" rid="article-20356.r17">[17]</xref><xref ref-type="bibr" rid="article-20356.r20">[20]</xref><xref ref-type="bibr" rid="article-20356.r21">[21]</xref><xref ref-type="bibr" rid="article-20356.r22">[22]</xref><xref ref-type="bibr" rid="article-20356.r23">[23]</xref><xref ref-type="bibr" rid="article-20356.r24">[24]</xref>&#x000a0;</p>
        <p>When worldwide DRPLA cases are counted for among the spinocerebellar ataxia (SCA), the rate in the Japanese population is 7&#x000a0;to 20%, with lower rates in other Asian populations (Singapore, 6%; Korea, 3%),&#x000a0;Portuguese families 2&#x000a0;to 4%, other European descent 0.25&#x000a0;to 1%,&#x000a0;and Latin-American families 0.14&#x000a0;to 3.1%.<xref ref-type="bibr" rid="article-20356.r15">[15]</xref>&#x000a0;It equally affects men and women. Juveline-onset disease or&#x000a0;progressive myoclonic epilepsy (PME) phenotype patients (less than 20 years of age), typically present with seizures and some form of neurodevelopment disorder.&#x000a0;Genotypically, they have longer CAG repeat lengths ( more than 65), and they have generalized seizures and myoclonus with progressive intellectual disability.<xref ref-type="bibr" rid="article-20356.r15">[15]</xref>&#x000a0;Adult-onset or without PME phenotype (more than 20 years of age),&#x000a0;on the&#x000a0;other hand, has symptoms that include ataxia, choreoathetosis, cognitive impairment, dementia, and psychiatric features. Additionally, they have shorter CAG repeat lengths (less than 65), with seizures being a rare symptom.</p>
      </sec>
      <sec id="article-20356.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Dentatorubral-pallidoluysian atrophy is one of the CAG repeat disorders that show atrophin-1 protein deposition in the nucleus of affected neurons, known as neuronal intranuclear inclusion (NII).&#x000a0;Polyglutamine (poly-Q) expansion characterizes autosomal-dominant neurodegenerative disorders such as Huntington disease (HD),&#x000a0;and six of the spinocerebellar ataxia (SCA) disorders, which could be an important pathogenic feature in common with DRPLA and may explain the&#x000a0;genetic anticipation and de novo expansion.<xref ref-type="bibr" rid="article-20356.r25">[25]</xref><xref ref-type="bibr" rid="article-20356.r26">[26]</xref><xref ref-type="bibr" rid="article-20356.r27">[27]</xref><xref ref-type="bibr" rid="article-20356.r28">[28]</xref>&#x000a0;</p>
        <p>Lysine-specific demethylase 1 (LSD1) and its target ATN1 may be responsible for neuronal pluripotent development of cells in the cortex.<xref ref-type="bibr" rid="article-20356.r29">[29]</xref> Animal models suggest that NII occurs without completed apoptosis, leading to poor clearance of aggregated polyQ inclusions.<xref ref-type="bibr" rid="article-20356.r30">[30]</xref> It is still unclear whether the inclusion is a pathogenic feature, or a&#x000a0;failed neuroprotective process, such as seen in HD.<xref ref-type="bibr" rid="article-20356.r26">[26]</xref><xref ref-type="bibr" rid="article-20356.r31">[31]</xref><xref ref-type="bibr" rid="article-20356.r32">[32]</xref></p>
        <p>Antibody mediated-immunohistochemistry, in DRPLA post-mortem brains,&#x000a0;shows polyglutamine protein structures or stretches that co-deposit with a mutant and insoluble ATN1 protein as part of a diffuse intraneuronal accumulation in densely packed areas within the NII. The dominant hypothesis is&#x000a0;that the number of NII correlates with clinical features such as dementia and epilepsy, with neuropathological studies showing reduced&#x000a0;number and size of spines and diameter of dendrites. All these findings could explain the brain atrophy&#x000a0;seen in neuroimaging.<xref ref-type="bibr" rid="article-20356.r15">[15]</xref></p>
      </sec>
      <sec id="article-20356.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Post-mortem studies of the patients suffering from dentatorubral-pallidoluysian atrophy show interesting features including atrophy in the entire spinal cord neuraxis, neuronal apoptosis, and astrocytosis in the dentatorubral and pallidoluysian systems (globus pallidus, red nucleus, and to a lesser degree, the dentate nucleus and subthalamic nucleus). It can cause severe diffuse cortical white matter disease. Frontal lobe and pontine atrophy are present in the juvenile-onset cases, characterized by a severe clinical phenotype with cognitive deterioration and seizures. Interestingly,&#x000a0;hippocampal regions are relatively spared.&#x000a0;</p>
        <p>Chemical staining for protein structures encoded by a mutant ATN1 protein shows poly-Q deposition of&#x000a0;diffuse intraneuronal accumulation within the nucleus of affected neurons. The latter are spherical, eosinophilic non-membrane bound structures that contain a mixture of granular and filamentous ubiquitinated structures, containing inclusions of the mutant ATN1 protein.<xref ref-type="bibr" rid="article-20356.r15">[15]</xref><xref ref-type="bibr" rid="article-20356.r33">[33]</xref><xref ref-type="bibr" rid="article-20356.r34">[34]</xref></p>
      </sec>
      <sec id="article-20356.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Clinical diagnosis of dentatorubral-pallidoluysian atrophy is challenging, given&#x000a0;heterogeneous phenotypes and similarities to spinocerebellar ataxias.&#x000a0;Symptoms and neuroimaging vary according to the age of onset. Late-onset DRPLA can sometimes present as isolated cerebellar ataxia, or dementia.<xref ref-type="bibr" rid="article-20356.r15">[15]</xref></p>
        <p>When it begins before the age of 20 it&#x000a0;typically exhibits:</p>
        <list list-type="bullet">
          <list-item>
            <p>Myoclonus</p>
          </list-item>
          <list-item>
            <p>Seizures of different types</p>
          </list-item>
          <list-item>
            <p>Behavioral changes</p>
          </list-item>
          <list-item>
            <p>Progressive intellectual disability and deterioration</p>
          </list-item>
          <list-item>
            <p>Ataxia</p>
          </list-item>
        </list>
        <p>When it begins after the age of 20 years it presents with:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Ataxia</p>
          </list-item>
          <list-item>
            <p>Choreoathetosis or dystonia</p>
          </list-item>
          <list-item>
            <p>Psychiatric symptoms (delusions)</p>
          </list-item>
          <list-item>
            <p>Dementia</p>
          </list-item>
          <list-item>
            <p>Rarely, head tremors and visual problems</p>
          </list-item>
        </list>
        <p>Exam findings include neurocognitive&#x000a0;impairment&#x000a0;on executive function, language, memory, dysmetria, cerebellar ataxia, motor weakness, upper motor neuron signs, and difficulties with gait.</p>
      </sec>
      <sec id="article-20356.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>There are no clinical diagnostic criteria for dentatorubral-pallidoluysian atrophy. Clinical symptoms,&#x000a0;family history, and ancestry can increase the yield of the targeted&#x000a0;molecular genetic testing.<xref ref-type="bibr" rid="article-20356.r35">[35]</xref><xref ref-type="bibr" rid="article-20356.r36">[36]</xref>&#x000a0;Genetic testing&#x000a0;consists of a polymerase chain reaction (PCR) amplification across the ATN1 CAG repeat region. To increase the sensitivity of the test in higher CAG repeats, a capillary electrophoresis-Southern Blot is used to confirm the diagnosis.</p>
        <p>Although whole-genome sequencing technologies are promising, they lack internal and external&#x000a0;validation for CAG expansion specific for DRPLA. An electroencephalogram (EEG) is used to guide management in the context of&#x000a0;suspicion of seizures. Focal motor seizures with impaired awareness progressing to generalized tonic-clonic seizures are the typical semiology.<xref ref-type="bibr" rid="article-20356.r37">[37]</xref><xref ref-type="bibr" rid="article-20356.r38">[38]</xref>&#x000a0;Brain magnetic resonance imaging (MRI) can show diffuse cerebellar and brainstem atrophy, diffuse periventricular white matter disease, but these are mostly non-specific.<xref ref-type="bibr" rid="article-20356.r39">[39]</xref><xref ref-type="bibr" rid="article-20356.r40">[40]</xref><xref ref-type="bibr" rid="article-20356.r41">[41]</xref><xref ref-type="bibr" rid="article-20356.r42">[42]</xref><xref ref-type="bibr" rid="article-20356.r43">[43]</xref><xref ref-type="bibr" rid="article-20356.r44">[44]</xref>&#x000a0;</p>
        <p>Hypoalbuminemia has also been studied as a possible biological marker, given that some studies show it is inversely correlated with CAG length.<xref ref-type="bibr" rid="article-20356.r15">[15]</xref><xref ref-type="bibr" rid="article-20356.r45">[45]</xref>&#x000a0;Although&#x000a0;next-generation sequencing technologies are promising,&#x000a0;they have not been widely used or validated&#x000a0;for the ATN1 repeat expansion.</p>
      </sec>
      <sec id="article-20356.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Unfortunately, there is no&#x000a0;cure for dentatorubral-pallidoluysian atrophy. Treatment is predominantly supportive. Genetic counseling of patients and their family members is essential given that the condition is autosomal dominant, with important ethical considerations before diagnosis disclosure.</p>
        <p>When there is clinical suspicion of seizures; selecting an anti-epileptic drug (AED) could be individualized to the predominant clinical scenario of the seizures. No AED is found superior to others in randomized controlled studies. However, levetiracetam and perampanel&#x000a0;show promise in juvenile-onset DRPLA.<xref ref-type="bibr" rid="article-20356.r38">[38]</xref><xref ref-type="bibr" rid="article-20356.r46">[46]</xref><xref ref-type="bibr" rid="article-20356.r47">[47]</xref>&#x000a0;Choreoathetoid and dystonic movements are treated with tetrabenazine, risperidone, and gabapentin.<xref ref-type="bibr" rid="article-20356.r42">[42]</xref><xref ref-type="bibr" rid="article-20356.r48">[48]</xref>&#x000a0;Consensus European guidelines show that riluzole (Class B evidence) or amantadine (Class&#x000a0;C evidence) can potentially improve ataxic symptoms.<xref ref-type="bibr" rid="article-20356.r49">[49]</xref><xref ref-type="bibr" rid="article-20356.r50">[50]</xref><xref ref-type="bibr" rid="article-20356.r51">[51]</xref><xref ref-type="bibr" rid="article-20356.r52">[52]</xref>&#x000a0;Given unknown teratogenicity, however, they are avoided in childbearing patients or currently pregnant patients.</p>
        <p>A neuropsychological and psychiatric assessment is instrumental for evaluating major neurocognitive deficits and associated mood disorders, for enhanced quality of life. Physical and occupational therapy is important to maintain functional activities of daily living. Structured and individualized&#x000a0;educational programs for children with the disease is another important consideration. Involving an interprofessional team of providers can help address all the co-morbidities associated with the disorder and enhance the number of quality life years. Avoiding general anesthesia during surgical procedures can decrease the rate of breakthrough seizures.<xref ref-type="bibr" rid="article-20356.r15">[15]</xref></p>
        <p>CAG repeat expansion disorder and developments in transcription silencing is a promising venue for curative treatment. This is currently used for SCA and HD with some success in animal&#x000a0;models. Ribonucleic acid (RNA) interference of multiple alleles is possible within the CNS, although it is costly and time-consuming, and still in an experimental phase. Another promising strategy is to use targeted RNA small molecules that affect the translation of mutant ATN-1 and has the advantage of crossing the blood-brain barrier. Challenges include poor absorption and allergic reactions.<xref ref-type="bibr" rid="article-20356.r15">[15]</xref><xref ref-type="bibr" rid="article-20356.r53">[53]</xref><xref ref-type="bibr" rid="article-20356.r54">[54]</xref><xref ref-type="bibr" rid="article-20356.r55">[55]</xref><xref ref-type="bibr" rid="article-20356.r56">[56]</xref></p>
      </sec>
      <sec id="article-20356.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The diagnosis of dentatorubral-pallidoluysian atrophy is challenging without a known family history of the disease. Clinical symptoms can mimic other familial degenerative or acquired ataxic disorders.&#x000a0;An extensive metabolic and genetic workup can be helpful if the diagnosis is unclear. Advanced imaging, along with cerebrospinal fluid and serum studies, may also help rule out other disorders.<xref ref-type="bibr" rid="article-20356.r15">[15]</xref><xref ref-type="bibr" rid="article-20356.r40">[40]</xref><xref ref-type="bibr" rid="article-20356.r57">[57]</xref></p>
        <p>Differential diagnoses for adult-onset DRPLA include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Huntington disease</p>
          </list-item>
          <list-item>
            <p>Spinocerebellar ataxia</p>
          </list-item>
          <list-item>
            <p>Atypical parkinsonism with cerebellar ataxia</p>
          </list-item>
          <list-item>
            <p>Alcohol</p>
          </list-item>
          <list-item>
            <p>Toxic/metabolic induced ataxias</p>
          </list-item>
          <list-item>
            <p>Ataxic paraneoplastic syndromes</p>
          </list-item>
        </list>
        <p>Differentials for juvenile-onset DRPLA are broad and include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Familial essential myoclonus and epilepsy</p>
          </list-item>
          <list-item>
            <p>Progressive myoclonic epilepsy</p>
          </list-item>
          <list-item>
            <p>Lafora disease</p>
          </list-item>
          <list-item>
            <p>Unverricht-Lundborg disease</p>
          </list-item>
          <list-item>
            <p>Infantile neuroaxonal dystrophy</p>
          </list-item>
          <list-item>
            <p>Neuroferritinopathy</p>
          </list-item>
          <list-item>
            <p>Myoclonus epilepsy associated with ragged red fibers</p>
          </list-item>
          <list-item>
            <p>Heoxosaminidase A deficiency</p>
          </list-item>
          <list-item>
            <p>Neuronal ceroid-lipofuscinosis</p>
          </list-item>
          <list-item>
            <p>Gaucher disease</p>
          </list-item>
          <list-item>
            <p>Sialidosis</p>
          </list-item>
          <list-item>
            <p>Galactosialidosis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20356.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>As there is no cure for dentatorubral-pallidoluysian atrophy, the mean&#x000a0;age at death is 49 years (range 18&#x02013;80 years); the median time from disease onset to death is 15 years.<xref ref-type="bibr" rid="article-20356.r13">[13]</xref>&#x000a0;The length of the CAG repeat expansion in ATN1 is positively correlated with age of onset, clinical symptoms, and longevity, with more than 48 repeats being linked to early-onset, severe disease phenotype, and a shorter lifespan. Functional impairment is also inversely correlated with CAG repeat length and lead to a poorer quality of life years and higher disability burden.<xref ref-type="bibr" rid="article-20356.r13">[13]</xref> Unfortunately,&#x000a0;DRPLA is classified as a microsatellite repeat disorder, which shows genetic anticipation with earlier onset and worse disease severity as it passes to the next generation of offsprings.<xref ref-type="bibr" rid="article-20356.r15">[15]</xref></p>
      </sec>
      <sec id="article-20356.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Many complications can arise from the comorbidity that comes with dentatorubral-pallidoluysian atrophy. Following are some of the complications such patients can have:</p>
        <list list-type="bullet">
          <list-item>
            <p>Progressive repetitive seizures</p>
          </list-item>
          <list-item>
            <p>Status epilepticus</p>
          </list-item>
          <list-item>
            <p>Solid/liquid dysphagia with potential aspiration pneumonia<xref ref-type="bibr" rid="article-20356.r13">[13]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20356.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>As dentatorubral-pallidoluysian atrophy is a disorder involving the neuromuscular system of the patient it requires input from an interprofessional team. This team may comprise of the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Adult or pediatric neurologists</p>
          </list-item>
          <list-item>
            <p>Epilepsy neurologists</p>
          </list-item>
          <list-item>
            <p>Geriatrics</p>
          </list-item>
          <list-item>
            <p>Pediatrics</p>
          </list-item>
          <list-item>
            <p>Geneticists</p>
          </list-item>
          <list-item>
            <p>Physical and occupational therapists</p>
          </list-item>
          <list-item>
            <p>Social workers</p>
          </list-item>
          <list-item>
            <p>Psychiatrists/psychologists</p>
          </list-item>
          <list-item>
            <p>Palliative medicine</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20356.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Dentatorubral-pallidoluysian atrophy is a significant and severe disease affecting parents and children of affected parents. Exhaustive counseling is needed for both generations. It is a hereditary disorder whose symptoms vary depending on whether they begin in childhood or adulthood. A parent with the disease has a 50% chance of passing it to their children, regardless of sex or gender; therefore,&#x000a0;genetic counseling is important.&#x000a0;It involves excessive protein deposition&#x000a0;in the cells of the CNS, causing dysfunction and leading to the death of brain cells.&#x000a0;There is no cure for this disorder.&#x000a0;Prognosis is poor,&#x000a0;mean disease duration is about 15 years, and life expectancy&#x000a0;8&#x000a0;to 16 years from symptom onset.&#x000a0;Early recognition of the disorder may improve patient understanding, and access to services and treatments.</p>
        <p><bold>Support Resources for Affected Patients and Families</bold>&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Seek a healthcare specialist for medical advice, you can find them through advocacy organizations, academic medical centers, clinical trials, or medical peer-reviewed articles published in medical journals.</p>
          </list-item>
          <list-item>
            <p>If unable to find a specialist in your local area, contact national or international specialists.</p>
          </list-item>
          <list-item>
            <p>Global organizations supporting this disease include the National Ataxia Foundation, Ataxia UK, European Federation of Hereditary Ataxias, Epilepsy Foundation, and RareConnect.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20356.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="bullet">
          <list-item>
            <p>Dentatorubral-pallidoluysian atrophy is a progressive, autosomal dominant CAG repeat disorder typically characterized by&#x000a0;ataxia, myoclonus, epilepsy, choreoathetosis, dementia, psychiatric disturbance, and progressive intellectual deterioration.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Juvenile onset (less than 20 years) disease presents with progressive myoclonus epilepsy disorder with ataxia and abnormal intellectual development, with recurrent severe seizures. The sudden unexpected death of someone with epilepsy (SUDEP) is the most deadly complication.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Adult-onset (more than 20 years) disease presents with dystonias, neurocognitive and neuropsychiatric decline with ataxia, with aspiration pneumonia as the most common cause of mortality.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>DRPLA is a microsatellite CAG repeat disorder with genetic anticipation affecting the atrophin-1 (ATN1) gene, leading to the intranuclear accumulation of protein deposits in affected neurons, ultimately leading to progressive neuronal dysfunction, atrophy, and death.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Pathogenic&#x000a0;CAG repeat length can range from 48 to 93. Complete penetrance has 48 tandem copies, incomplete penetrance clinical phenotype has 35&#x02013;47, and normal is less than 35.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Japanese patients have a higher baseline of CAG repeats (20-35) compared to individuals from European&#x000a0;descent, which could explain their increased susceptibility to the disease.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Prognosis is poor,&#x000a0;mean disease duration is about 15 years, and life expectancy is 8&#x02013;16 years from symptom onset. The length of the ATN1 CAG repeat expansion is directly correlated with the age of onset, clinical phenotype, and life expectancy.</p>
          </list-item>
          <list-item>
            <p>Highly suspicious cases for DRPLA are further evaluated by targeted&#x000a0;molecular genetic testing: PCR amplification across the ATN1 CAG repeat region; for higher CAG repeats, ancillary Southern Blot electrophoresis, is used to confirm the diagnosis.</p>
          </list-item>
          <list-item>
            <p>EEG and MRI are helpful for certain clinical scenarios, but they are mostly non-specific for the disorder.</p>
          </list-item>
          <list-item>
            <p>Treatment is predominantly supportive: symptomatic treatment of seizures, ataxias, choreoathetosis, as well as nonpharmacological interventions such as special education programs for children, neurorehabilitation, neuropsychological and neuropsychiatric, and most importantly, genetic counseling. &#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Avoiding general anesthesia during surgical procedures can decrease the rate of breakthrough seizures.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20356.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>An interprofessional team that provides a holistic and integrated approach is important&#x000a0;in patients with DRPLA,&#x000a0;to reach diagnosis sooner, provide symptomatic control of co-morbidities, maximize life expectancy and the quality of life for patients with this devastating disorder.<xref ref-type="bibr" rid="article-20356.r58">[58]</xref> Collaborative patient-centered decision-making and coordination of care between primary providers and subspecialists are essential to avoid gaps in care and improve health outcomes.&#x000a0;Education, physiotherapy, occupational therapy, genetic counseling, and environmental&#x000a0;adaptation may also be needed at different disease stages. Serious complications may need to be addressed in an intensive care unit. Palliative care can be considered&#x000a0;during the late stages of the disease.<xref ref-type="bibr" rid="article-20356.r59">[59]</xref><xref ref-type="bibr" rid="article-20356.r60">[60]</xref><xref ref-type="bibr" rid="article-20356.r61">[61]</xref><xref ref-type="bibr" rid="article-20356.r62">[62]</xref><xref ref-type="bibr" rid="article-20356.r63">[63]</xref>&#x000a0;[Level 1]</p>
      </sec>
      <sec id="article-20356.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20356&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20356">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/dentatorubral-pallidoluysian-atrophy/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=20356">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20356/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20356">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-20356.s18">
        <title>References</title>
        <ref id="article-20356.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Malek</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Greene</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The progressive myoclonic epilepsies.</article-title>
            <source>Pract Neurol</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>15</volume>
            <issue>3</issue>
            <fpage>164</fpage>
            <page-range>164-71</page-range>
            <pub-id pub-id-type="pmid">25720773</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hatano</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Okuma</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Iijima</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fujishima</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Goto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mizuno</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Cervical dystonia in dentatorubral-pallidoluysian atrophy.</article-title>
            <source>Acta Neurol Scand</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>108</volume>
            <issue>4</issue>
            <fpage>287</fpage>
            <page-range>287-9</page-range>
            <pub-id pub-id-type="pmid">12956864</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsuji</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Dentatorubral-pallidoluysian atrophy.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2012</year>
            <volume>103</volume>
            <fpage>587</fpage>
            <page-range>587-94</page-range>
            <pub-id pub-id-type="pmid">21827919</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lindsay</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Storey</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Cognitive Changes in the Spinocerebellar Ataxias Due to Expanded Polyglutamine Tracts: A Survey of the Literature.</article-title>
            <source>Brain Sci</source>
            <year>2017</year>
            <month>Jul</month>
            <day>14</day>
            <volume>7</volume>
            <issue>7</issue>
            <pub-id pub-id-type="pmid">28708110</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adachi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Arima</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Asada</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kato</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Minami</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Goto Yi</surname>
              </name>
              <name>
                <surname>Onuma</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ikeuchi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tsuji</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hayashi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fukutani</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Dentatorubral-pallidoluysian atrophy (DRPLA) presenting with psychosis.</article-title>
            <source>J Neuropsychiatry Clin Neurosci</source>
            <year>2001</year>
            <season>Spring</season>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>258</fpage>
            <page-range>258-60</page-range>
            <pub-id pub-id-type="pmid">11449034</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ito</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Yamada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kawai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Usui</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hamada</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fukuuchi</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Corneal endothelial degeneration in dentatorubral-pallidoluysian atrophy.</article-title>
            <source>Arch Neurol</source>
            <year>2002</year>
            <month>Feb</month>
            <volume>59</volume>
            <issue>2</issue>
            <fpage>289</fpage>
            <page-range>289-91</page-range>
            <pub-id pub-id-type="pmid">11843701</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ohizumi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Okuma</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Fukae</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fujishima</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Goto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mizuno</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Head tremor in dentatorubral-pallidoluysian atrophy.</article-title>
            <source>Acta Neurol Scand</source>
            <year>2002</year>
            <month>Nov</month>
            <volume>106</volume>
            <issue>5</issue>
            <fpage>319</fpage>
            <page-range>319-21</page-range>
            <pub-id pub-id-type="pmid">12371928</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Silver</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Sethi</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Nichols</surname>
                <given-names>FT</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Case report of optic atrophy in Dentatorubropallidoluysian Atrophy (DRPLA).</article-title>
            <source>BMC Neurol</source>
            <year>2015</year>
            <month>Dec</month>
            <day>18</day>
            <volume>15</volume>
            <fpage>260</fpage>
            <pub-id pub-id-type="pmid">26679169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>TITICA</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>VAN BOGAERT</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Heredo-degenerative hemiballismus; a contribution to the question of primary atrophy of the corpus luysii.</article-title>
            <source>Brain</source>
            <year>1946</year>
            <month>Dec</month>
            <volume>69</volume>
            <issue>4</issue>
            <fpage>251</fpage>
            <page-range>251-63</page-range>
            <pub-id pub-id-type="pmid">20287644</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>SMITH</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>GONDA</surname>
                <given-names>VE</given-names>
              </name>
              <name>
                <surname>MALAMUD</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Unusual form of cerebellar ataxia; combined dentato-rubral and pallido-Luysian degeneration.</article-title>
            <source>Neurology</source>
            <year>1958</year>
            <month>Mar</month>
            <volume>8</volume>
            <issue>3</issue>
            <fpage>205</fpage>
            <page-range>205-9</page-range>
            <pub-id pub-id-type="pmid">13517487</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nagafuchi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yanagisawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shirayama</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ohsaki</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bundo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Takeda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tadokoro</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kondo</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Murayama</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p.</article-title>
            <source>Nat Genet</source>
            <year>1994</year>
            <month>Jan</month>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>14</fpage>
            <page-range>14-8</page-range>
            <pub-id pub-id-type="pmid">8136826</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bidollari</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rotundo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Altieri</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Amicucci</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wiquel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ferrari</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Goldoni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bernardini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Consoli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>De Luca</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fanelli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lamorte</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>D'Agruma</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Vescovi</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Squitieri</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rosati</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Generation of induced pluripotent stem cell line CSSi008-A (4698) from a patient affected by advanced stage of Dentato-Rubral-Pallidoluysian atrophy (DRPLA).</article-title>
            <source>Stem Cell Res</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>40</volume>
            <fpage>101551</fpage>
            <pub-id pub-id-type="pmid">31493762</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hasegawa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ikeuchi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Koike</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Matsubara</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tsuchiya</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nozaki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Homma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Idezuka</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nishizawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Onodera</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Long-term disability and prognosis in dentatorubral-pallidoluysian atrophy: a correlation with CAG repeat length.</article-title>
            <source>Mov Disord</source>
            <year>2010</year>
            <month>Aug</month>
            <day>15</day>
            <volume>25</volume>
            <issue>11</issue>
            <fpage>1694</fpage>
            <page-range>1694-700</page-range>
            <pub-id pub-id-type="pmid">20589872</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maruyama</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Saito</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nakagawa</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Saito</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Komaki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sugai</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sasaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kumada</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Saito</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Minami</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Goto</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Importance of CAG repeat length in childhood-onset dentatorubral-pallidoluysian atrophy.</article-title>
            <source>J Neurol</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>259</volume>
            <issue>11</issue>
            <fpage>2329</fpage>
            <page-range>2329-34</page-range>
            <pub-id pub-id-type="pmid">22527233</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carroll</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Massey</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Wardle</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Peall</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <article-title>Dentatorubral-pallidoluysian Atrophy: An Update.</article-title>
            <source>Tremor Other Hyperkinet Mov (N Y)</source>
            <year>2018</year>
            <volume>8</volume>
            <fpage>577</fpage>
            <pub-id pub-id-type="pmid">30410817</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yamada</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Dentatorubral-pallidoluysian atrophy (DRPLA): The 50th Anniversary of Japanese Society of Neuropathology.</article-title>
            <source>Neuropathology</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>30</volume>
            <issue>5</issue>
            <fpage>453</fpage>
            <page-range>453-7</page-range>
            <pub-id pub-id-type="pmid">20500452</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wardle</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Robertson</surname>
                <given-names>NP</given-names>
              </name>
            </person-group>
            <article-title>Clinical and genetic characteristics of non-Asian dentatorubral-pallidoluysian atrophy: A systematic review.</article-title>
            <source>Mov Disord</source>
            <year>2009</year>
            <month>Aug</month>
            <day>15</day>
            <volume>24</volume>
            <issue>11</issue>
            <fpage>1636</fpage>
            <page-range>1636-40</page-range>
            <pub-id pub-id-type="pmid">19514013</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsuji</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Onodera</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Goto</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nishizawa</surname>
                <given-names>M</given-names>
              </name>
              <collab>Study Group on Ataxic Diseases</collab>
            </person-group>
            <article-title>Sporadic ataxias in Japan--a population-based epidemiological study.</article-title>
            <source>Cerebellum</source>
            <year>2008</year>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>189</fpage>
            <page-range>189-97</page-range>
            <pub-id pub-id-type="pmid">18418674</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>IH</given-names>
              </name>
              <name>
                <surname>Soong</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>YC</given-names>
              </name>
            </person-group>
            <article-title>Dentatorubropallidoluysian atrophy in Chinese.</article-title>
            <source>Arch Neurol</source>
            <year>2001</year>
            <month>Nov</month>
            <volume>58</volume>
            <issue>11</issue>
            <fpage>1905</fpage>
            <page-range>1905-8</page-range>
            <pub-id pub-id-type="pmid">11709002</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coutinho</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ruano</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Loureiro</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Cruz</surname>
                <given-names>VT</given-names>
              </name>
              <name>
                <surname>Barros</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tuna</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Barbot</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Guimar&#x000e3;es</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Alonso</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Silveira</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sequeiros</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Marques Neves</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Serrano</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Hereditary ataxia and spastic paraplegia in Portugal: a population-based prevalence study.</article-title>
            <source>JAMA Neurol</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>70</volume>
            <issue>6</issue>
            <fpage>746</fpage>
            <page-range>746-55</page-range>
            <pub-id pub-id-type="pmid">23609960</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Erichsen</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Koht</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stray-Pedersen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abdelnoor</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tallaksen</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based study.</article-title>
            <source>Brain</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>132</volume>
            <issue>Pt 6</issue>
            <fpage>1577</fpage>
            <page-range>1577-88</page-range>
            <pub-id pub-id-type="pmid">19339254</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yi&#x0015f;</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Dirik</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>G&#x000fc;ndo&#x0011f;du-Eken</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ba&#x0015f;ak</surname>
                <given-names>AN</given-names>
              </name>
            </person-group>
            <article-title>Dentatorubral pallidoluysian atrophy in a Turkish family.</article-title>
            <source>Turk J Pediatr</source>
            <year>2009</year>
            <season>Nov-Dec</season>
            <volume>51</volume>
            <issue>6</issue>
            <fpage>610</fpage>
            <page-range>610-2</page-range>
            <pub-id pub-id-type="pmid">20196398</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dest&#x000e9;e</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Delalande</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Vuillaume</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Schraen-Maschke</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Defebvre</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sablonni&#x000e8;re</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>The first identified French family with dentatorubral-pallidoluysian atrophy.</article-title>
            <source>Mov Disord</source>
            <year>2000</year>
            <month>Sep</month>
            <volume>15</volume>
            <issue>5</issue>
            <fpage>996</fpage>
            <page-range>996-9</page-range>
            <pub-id pub-id-type="pmid">11009212</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martins</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Matam&#x000e1;</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Guimar&#x000e3;es</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Vale</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Guimar&#x000e3;es</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ramos</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Coutinho</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sequeiros</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Silveira</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Portuguese families with dentatorubropallidoluysian atrophy (DRPLA) share a common haplotype of Asian origin.</article-title>
            <source>Eur J Hum Genet</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>11</volume>
            <issue>10</issue>
            <fpage>808</fpage>
            <page-range>808-11</page-range>
            <pub-id pub-id-type="pmid">14512972</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tunc</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tadic</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Z&#x000fc;hlke</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hellenbroich</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Br&#x000fc;ggemann</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Pearls &#x00026; Oy-sters: Family history of Huntington disease disguised a case of dentatorubral-pallidoluysian atrophy.</article-title>
            <source>Neurology</source>
            <year>2018</year>
            <month>Jan</month>
            <day>16</day>
            <volume>90</volume>
            <issue>3</issue>
            <fpage>142</fpage>
            <page-range>142-143</page-range>
            <pub-id pub-id-type="pmid">29335306</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Charroux</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fanto</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The fine line between waste disposal and recycling: DRPLA fly models illustrate the importance of completing the autophagy cycle for rescuing neurodegeneration.</article-title>
            <source>Autophagy</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>6</volume>
            <issue>5</issue>
            <fpage>667</fpage>
            <page-range>667-9</page-range>
            <pub-id pub-id-type="pmid">20543566</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stevanin</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Giunti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Belal</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>D&#x000fc;rr</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ruberg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wood</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Brice</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>De novo expansion of intermediate alleles in spinocerebellar ataxia 7.</article-title>
            <source>Hum Mol Genet</source>
            <year>1998</year>
            <month>Oct</month>
            <volume>7</volume>
            <issue>11</issue>
            <fpage>1809</fpage>
            <page-range>1809-13</page-range>
            <pub-id pub-id-type="pmid">9736784</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Keo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Aziz</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Dzyubachyk</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>van der Grond</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>van Roon-Mom</surname>
                <given-names>WMC</given-names>
              </name>
              <name>
                <surname>Lelieveldt</surname>
                <given-names>BPF</given-names>
              </name>
              <name>
                <surname>Reinders</surname>
                <given-names>MJT</given-names>
              </name>
              <name>
                <surname>Mahfouz</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Co-expression Patterns between <italic>ATN1</italic> and <italic>ATXN2</italic> Coincide with Brain Regions Affected in Huntington's Disease.</article-title>
            <source>Front Mol Neurosci</source>
            <year>2017</year>
            <volume>10</volume>
            <fpage>399</fpage>
            <pub-id pub-id-type="pmid">29249939</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Yuan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Epigenetic regulation of Atrophin1 by lysine-specific demethylase 1 is required for cortical progenitor maintenance.</article-title>
            <source>Nat Commun</source>
            <year>2014</year>
            <month>Dec</month>
            <day>18</day>
            <volume>5</volume>
            <fpage>5815</fpage>
            <pub-id pub-id-type="pmid">25519973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suzuki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nakayama</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hashimoto</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yazawa</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Proteolytic processing regulates pathological accumulation in dentatorubral-pallidoluysian atrophy.</article-title>
            <source>FEBS J</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>277</volume>
            <issue>23</issue>
            <fpage>4873</fpage>
            <page-range>4873-87</page-range>
            <pub-id pub-id-type="pmid">20977674</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arrasate</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mitra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schweitzer</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Segal</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Finkbeiner</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death.</article-title>
            <source>Nature</source>
            <year>2004</year>
            <month>Oct</month>
            <day>14</day>
            <volume>431</volume>
            <issue>7010</issue>
            <fpage>805</fpage>
            <page-range>805-10</page-range>
            <pub-id pub-id-type="pmid">15483602</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Arrasate</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shaby</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Mitra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Masliah</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Finkbeiner</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis.</article-title>
            <source>J Neurosci</source>
            <year>2010</year>
            <month>Aug</month>
            <day>04</day>
            <volume>30</volume>
            <issue>31</issue>
            <fpage>10541</fpage>
            <page-range>10541-50</page-range>
            <pub-id pub-id-type="pmid">20685997</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suzuki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yamada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tsuji</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>DRPLA: recent advances in research using transgenic mouse models.</article-title>
            <source>Methods Mol Biol</source>
            <year>2013</year>
            <volume>1010</volume>
            <fpage>277</fpage>
            <page-range>277-92</page-range>
            <pub-id pub-id-type="pmid">23754232</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yamada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shimohata</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tsuji</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Polyglutamine disease: recent advances in the neuropathology of dentatorubral-pallidoluysian atrophy.</article-title>
            <source>Neuropathology</source>
            <year>2006</year>
            <month>Aug</month>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>346</fpage>
            <page-range>346-51</page-range>
            <pub-id pub-id-type="pmid">16961072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dunn</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Albury</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Maksemous</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Benton</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Sutherland</surname>
                <given-names>HG</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Haupt</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Griffiths</surname>
                <given-names>LR</given-names>
              </name>
            </person-group>
            <article-title>Next Generation Sequencing Methods for Diagnosis of Epilepsy Syndromes.</article-title>
            <source>Front Genet</source>
            <year>2018</year>
            <volume>9</volume>
            <fpage>20</fpage>
            <pub-id pub-id-type="pmid">29467791</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jiang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Application of next-generation sequencing technologies in Neurology.</article-title>
            <source>Ann Transl Med</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>2</volume>
            <issue>12</issue>
            <fpage>125</fpage>
            <pub-id pub-id-type="pmid">25568878</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Egawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kubota</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kubota</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Inoue</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Fujiwara</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Onodera</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Electroclinical features of epilepsy in patients with juvenile type dentatorubral-pallidoluysian atrophy.</article-title>
            <source>Epilepsia</source>
            <year>2008</year>
            <month>Dec</month>
            <volume>49</volume>
            <issue>12</issue>
            <fpage>2041</fpage>
            <page-range>2041-9</page-range>
            <pub-id pub-id-type="pmid">18616556</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kobayashi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Takeuchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Oka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Akiyama</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ohtsuka</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Amelioration of disabling myoclonus in a case of DRPLA by levetiracetam.</article-title>
            <source>Brain Dev</source>
            <year>2012</year>
            <month>May</month>
            <volume>34</volume>
            <issue>5</issue>
            <fpage>368</fpage>
            <page-range>368-71</page-range>
            <pub-id pub-id-type="pmid">21889282</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sugiyama</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nakata</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kimura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Enokizono</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Maekawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kondo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kuwabara</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Matsuda</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Clinical and magnetic resonance imaging features of elderly onset dentatorubral-pallidoluysian atrophy.</article-title>
            <source>J Neurol</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>265</volume>
            <issue>2</issue>
            <fpage>322</fpage>
            <page-range>322-329</page-range>
            <pub-id pub-id-type="pmid">29236168</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yoon</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Youn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Is cerebral white matter involvement helpful in the diagnosis of dentatorubral-pallidoluysian atrophy?</article-title>
            <source>J Neurol</source>
            <year>2012</year>
            <month>Aug</month>
            <volume>259</volume>
            <issue>8</issue>
            <fpage>1694</fpage>
            <page-range>1694-7</page-range>
            <pub-id pub-id-type="pmid">22286658</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sunami</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Koide</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Arai</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yamada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mizutani</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Oyanagi</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Radiologic and neuropathologic findings in patients in a family with dentatorubral-pallidoluysian atrophy.</article-title>
            <source>AJNR Am J Neuroradiol</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>109</fpage>
            <page-range>109-14</page-range>
            <pub-id pub-id-type="pmid">20966051</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mu&#x000f1;oz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Campdelacreu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ferrer</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Rey</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Cardozo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>G&#x000f3;mez</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Tolosa</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Severe cerebral white matter involvement in a case of dentatorubropallidoluysian atrophy studied at autopsy.</article-title>
            <source>Arch Neurol</source>
            <year>2004</year>
            <month>Jun</month>
            <volume>61</volume>
            <issue>6</issue>
            <fpage>946</fpage>
            <page-range>946-9</page-range>
            <pub-id pub-id-type="pmid">15210537</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simpson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kent</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Roxburgh</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Neurological picture. Distinctive MRI abnormalities in a man with dentatorubral-pallidoluysian atrophy.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>2012</year>
            <month>May</month>
            <volume>83</volume>
            <issue>5</issue>
            <fpage>529</fpage>
            <page-range>529-30</page-range>
            <pub-id pub-id-type="pmid">22362920</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Souza</surname>
                <given-names>PV</given-names>
              </name>
              <name>
                <surname>Batistella</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>Pinto</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Teaching NeuroImages: Leukodystrophy and progressive myoclonic epilepsy disclosing DRPLA.</article-title>
            <source>Neurology</source>
            <year>2016</year>
            <month>Feb</month>
            <day>09</day>
            <volume>86</volume>
            <issue>6</issue>
            <fpage>e58</fpage>
            <page-range>e58-9</page-range>
            <pub-id pub-id-type="pmid">26857957</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nagai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Saito</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Endo</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Saito</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sugai</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ishiyama</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Komaki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nakagawa</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sasaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Saito</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sukigara</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Goto</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Matsuoka</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Hypoalbuminemia in early onset dentatorubral-pallidoluysian atrophy due to leakage of albumin in multiple organs.</article-title>
            <source>J Neurol</source>
            <year>2013</year>
            <month>May</month>
            <volume>260</volume>
            <issue>5</issue>
            <fpage>1263</fpage>
            <page-range>1263-71</page-range>
            <pub-id pub-id-type="pmid">23263592</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shiraishi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Egawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kawano</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Asahina</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kohsaka</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of perampanel for controlling seizures and improving neurological dysfunction in a patient with dentatorubral-pallidoluysian atrophy (DRPLA).</article-title>
            <source>Epilepsy Behav Case Rep</source>
            <year>2017</year>
            <volume>8</volume>
            <fpage>44</fpage>
            <page-range>44-46</page-range>
            <pub-id pub-id-type="pmid">28856097</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hamada</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shimakawa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Satomura</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Naito</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hashimoto</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>[Successful treatment of epilepsy and circadian rhythm disturbance with levetiracetam in a patient with dentatorubral-pallidoluysian atrophy (DRPLA)].</article-title>
            <source>No To Hattatsu</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>46</volume>
            <issue>6</issue>
            <fpage>439</fpage>
            <page-range>439-42</page-range>
            <pub-id pub-id-type="pmid">25558587</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gazulla</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Errea</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Benavente</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Tordesillas</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Treatment of ataxia in cortical cerebellar atrophy with the GABAergic drug gabapentin. A preliminary study.</article-title>
            <source>Eur Neurol</source>
            <year>2004</year>
            <volume>52</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-11</page-range>
            <pub-id pub-id-type="pmid">15218338</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van de Warrenburg</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>van Gaalen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Boesch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Burgunder</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>D&#x000fc;rr</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Giunti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Klockgether</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mariotti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pandolfo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Riess</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>EFNS/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood.</article-title>
            <source>Eur J Neurol</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>552</fpage>
            <page-range>552-62</page-range>
            <pub-id pub-id-type="pmid">24418350</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ristori</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Romano</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Visconti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cannoni</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Spadaro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Frontali</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pontieri</surname>
                <given-names>FE</given-names>
              </name>
              <name>
                <surname>Vanacore</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Salvetti</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial.</article-title>
            <source>Neurology</source>
            <year>2010</year>
            <month>Mar</month>
            <day>09</day>
            <volume>74</volume>
            <issue>10</issue>
            <fpage>839</fpage>
            <page-range>839-45</page-range>
            <pub-id pub-id-type="pmid">20211908</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Romano</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Coarelli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Marcotulli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Leonardi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Piccolo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Spadaro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Frontali</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ferraldeschi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vulpiani</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Ponzelli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Salvetti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Orzi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Petrucci</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vanacore</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Casali</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ristori</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial.</article-title>
            <source>Lancet Neurol</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>14</volume>
            <issue>10</issue>
            <fpage>985</fpage>
            <page-range>985-91</page-range>
            <pub-id pub-id-type="pmid">26321318</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Botez</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Botez-Marquard</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Elie</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pedraza</surname>
                <given-names>OL</given-names>
              </name>
              <name>
                <surname>Goyette</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lalonde</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Amantadine hydrochloride treatment in heredodegenerative ataxias: a double blind study.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>1996</year>
            <month>Sep</month>
            <volume>61</volume>
            <issue>3</issue>
            <fpage>259</fpage>
            <page-range>259-64</page-range>
            <pub-id pub-id-type="pmid">8795596</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kotowska-Zimmer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ostrovska</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Olejniczak</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Universal RNAi Triggers for the Specific Inhibition of Mutant Huntingtin, Atrophin-1, Ataxin-3, and Ataxin-7 Expression.</article-title>
            <source>Mol Ther Nucleic Acids</source>
            <year>2020</year>
            <month>Mar</month>
            <day>06</day>
            <volume>19</volume>
            <fpage>562</fpage>
            <page-range>562-571</page-range>
            <pub-id pub-id-type="pmid">31927329</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kong</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Qin</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Jin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>XJ</given-names>
              </name>
            </person-group>
            <article-title>CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington's disease.</article-title>
            <source>J Clin Invest</source>
            <year>2017</year>
            <month>Jun</month>
            <day>30</day>
            <volume>127</volume>
            <issue>7</issue>
            <fpage>2719</fpage>
            <page-range>2719-2724</page-range>
            <pub-id pub-id-type="pmid">28628038</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drouet</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ruiz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zala</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Feyeux</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Auregan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cambon</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Troquier</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Carpentier</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Aubert</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Merienne</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bourgois-Rocha</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hassig</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rey</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dufour</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Saudou</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Perrier</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Hantraye</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>D&#x000e9;glon</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Allele-specific silencing of mutant huntingtin in rodent brain and human stem cells.</article-title>
            <source>PLoS One</source>
            <year>2014</year>
            <volume>9</volume>
            <issue>6</issue>
            <fpage>e99341</fpage>
            <pub-id pub-id-type="pmid">24926995</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verma</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bhagwat</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Exploring the Potential of Small Molecule-Based Therapeutic Approaches for Targeting Trinucleotide Repeat Disorders.</article-title>
            <source>Mol Neurobiol</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>57</volume>
            <issue>1</issue>
            <fpage>566</fpage>
            <page-range>566-584</page-range>
            <pub-id pub-id-type="pmid">31399954</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kobayashi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nagao</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kawata</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Matsubara</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>A case of late adult-onset dentatorubral-pallidoluysian atrophy mimicking central pontine myelinolysis.</article-title>
            <source>J Neurol</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>256</volume>
            <issue>8</issue>
            <fpage>1369</fpage>
            <page-range>1369-71</page-range>
            <pub-id pub-id-type="pmid">19390768</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ilg</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Synofzik</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Br&#x000f6;tz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Burkard</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Giese</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Sch&#x000f6;ls</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Intensive coordinative training improves motor performance in degenerative cerebellar disease.</article-title>
            <source>Neurology</source>
            <year>2009</year>
            <month>Dec</month>
            <day>01</day>
            <volume>73</volume>
            <issue>22</issue>
            <fpage>1823</fpage>
            <page-range>1823-30</page-range>
            <pub-id pub-id-type="pmid">19864636</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fonteyn</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Keus</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Verstappen</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>van de Warrenburg</surname>
                <given-names>BP</given-names>
              </name>
            </person-group>
            <article-title>Physiotherapy in degenerative cerebellar ataxias: utilisation, patient satisfaction, and professional expertise.</article-title>
            <source>Cerebellum</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>12</volume>
            <issue>6</issue>
            <fpage>841</fpage>
            <page-range>841-7</page-range>
            <pub-id pub-id-type="pmid">23733611</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fonteyn</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Keus</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Verstappen</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Sch&#x000f6;ls</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>de Groot</surname>
                <given-names>IJ</given-names>
              </name>
              <name>
                <surname>van de Warrenburg</surname>
                <given-names>BP</given-names>
              </name>
            </person-group>
            <article-title>The effectiveness of allied health care in patients with ataxia: a systematic review.</article-title>
            <source>J Neurol</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>261</volume>
            <issue>2</issue>
            <fpage>251</fpage>
            <page-range>251-8</page-range>
            <pub-id pub-id-type="pmid">23589192</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hartley</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cassidy</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bunn</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pizer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Carter</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Exercise and Physical Therapy Interventions for Children with Ataxia: A Systematic Review.</article-title>
            <source>Cerebellum</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>18</volume>
            <issue>5</issue>
            <fpage>951</fpage>
            <page-range>951-968</page-range>
            <pub-id pub-id-type="pmid">31392562</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miyai</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hattori</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mihara</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hatakenaka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yagura</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sobue</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nishizawa</surname>
                <given-names>M</given-names>
              </name>
              <collab>Cerebellar Ataxia Rehabilitation Trialists Collaboration</collab>
            </person-group>
            <article-title>Cerebellar ataxia rehabilitation trial in degenerative cerebellar diseases.</article-title>
            <source>Neurorehabil Neural Repair</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>26</volume>
            <issue>5</issue>
            <fpage>515</fpage>
            <page-range>515-22</page-range>
            <pub-id pub-id-type="pmid">22140200</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20356.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ilg</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bastian</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Boesch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Burciu</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Celnik</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Claa&#x000df;en</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Feil</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kalla</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Miyai</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Nachbauer</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Sch&#x000f6;ls</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Strupp</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Synofzik</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Teufel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Timmann</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Consensus paper: management of degenerative cerebellar disorders.</article-title>
            <source>Cerebellum</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>248</fpage>
            <page-range>248-68</page-range>
            <pub-id pub-id-type="pmid">24222635</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
